although there were no significant patient characteristic differences between the dcp and dcp + bcg treatment groups , the addition of cisplatin to the dc + bcg regimen resulted in significantly prolonged response ( p less than 0.03 ) and survival ( p less than 0.002 ) durations .
C0280547
dcp
C0008838
cisplatin